Latest News for: gaba

Edit

Delhiites jam with Milind Gaba and Ritviz, munch on viral faves

The Times of India 05 Dec 2025
Singers Millind Gaba and Ritviz enthralled the crowd with their live performances. A go-to spot for coffee, food and musicThe fest featured an insane food lineup.
Edit

Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy

Nasdaq Globe Newswire 06 Nov 2025
Axsome obtains exclusive global rights to AZD7325, a novel oral selective GABAA α2,3 receptor positive allosteric modulator ... .
Edit

Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator

Enid News & Eagle 06 Nov 2025
Axsome obtains exclusive global rights to AZD7325, a novel oral selective GABAAα2,3 receptor positive allosteric modulator ... .
Edit

Atlantic Cape President Gaba to retire in 2026

Atlantic City 30 Oct 2025
Barbara Gaba, the president of Atlantic Cape Community College for the past nine years, will retire at the end of June, the school said Wednesday ... .
Edit

Ghosts, Goblins, and Gaba-Ghouls! Crave Greenlights Reality Ghost Hunting Series, SNOOKI: PARANORMAL ROOKIE

Canada Newswire 30 Oct 2025
TORONTO, Oct. 30, 2025 /CNW/ - Crave announced today an eight-episode order for SNOOKI ... Produced by Buck Productions in association with My Entertainment, and in partnership with Crave, the Crave Original series is set to premiere in 2026 ... .
Edit

GABA

Time Out Dubai 23 Oct 2025
It doesn’t feel like GABA is the latest to jump ....
Edit

food-induced ADHD and the influence of probiotics on oxytocin, GABA and BDNF

Rumble 08 Oct 2025
Click the Rumble article link to see the video ....
Edit

Ovid announces positive topline results for the next-generation GABA-aminotransferase

The Eagle-Tribune 03 Oct 2025
An expansive biomarker study confirmed OV329 delivered ...
Edit

Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory ...

Nasdaq Globe Newswire 03 Oct 2025
... generation GABA-aminotransferase (GABA-AT) inhibitor being developed for drug-resistant epilepsies.
Edit

Ovid announces positive topline results for the next-generation GABA- aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile (Form 8-K) (Ovid Therapeutics Inc)

Public Technologies 03 Oct 2025
... the safety, tolerability, pharmacokinetic (PK) and pharmacodynamic (PD) activity of OV329, a next generation GABA-aminotransferase (GABA-AT) inhibitor being developed for drug-resistant epilepsies.
  • 1

Article Search

tools
×
×
×
×